Literature DB >> 7445937

Influence of sodium nitroprusside and dobutamine on the haemodynamic effects produced by each other.

O A Meretoja.   

Abstract

To determine the possible modifying influence of potent inotropic medication and of sodium nitroprusside on the haemodynamic effects produced by each other, ten patients were treated 4 h after open-heart surgery with constant infusions of nitroprusside (NP) and dobutamine (DOB), separately and in combination. In consequence of reduced left ventricular filling pressure, NP produced, the cardiac index fell tolerably, although systemic and pulmonary vascular resistances were typically lowered. These haemodynamic effects of NP were identical, with and without simultaneous DOB-infusion. Dobutamine (6 microgram/kg/min) did not affect systemic or pulmonary arterial mean pressures, nor the filling pressures of right or ventricle. It augmented the cardiac index by 18%, but as a result of a 17 beats/min rise in heart rate, the stroke volume remained unchanged during DOB-infusion, whereas systemic vascular resistance was significantly lowered. The cardiovascular responses to DOB were independent of the simultaneous NP infusion. To conclude, the haemodynamic changes brought about by NP or DOB are not affected by each other, but when combined they produce additive, beneficial haemodynamic effects. Myocardial oxygen consumption, reflected as the rate-pressure-product (R-P-P), was slightly reduced during the combination therapy, due to the summation of the marked decrease of R-P-P which NP produced and the moderate increase of R-P-P produced by DOB.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7445937     DOI: 10.1111/j.1399-6576.1980.tb01533.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  1 in total

1.  Automatic regulation of hemodynamic variables in acute heart failure by a multiple adaptive predictive controller based on neural networks.

Authors:  Koji Kashihara
Journal:  Ann Biomed Eng       Date:  2006-10-18       Impact factor: 3.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.